Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. In addition, it provides nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, compressors, patient lifts, walkers, products for wound care, and medical equipment for home-based sleep apnea and chronic obstructive pulmonary disease treatments, as well as rents respiratory equipment. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
Employees - 1200,
CEO - Mr. Gregory J. Crawford,
Sector - Healthcare,
Country - US,
Market Cap - 92.96M
Altman ZScore(max is 10): 0.39, Piotroski Score(max is 10): 6, Working Capital: $13632000, Total Assets: $169677000, Retained Earnings: $-174697000, EBIT: 3828571, Total Liabilities: $141075000, Revenue: $235354000
- Current Price $2.14 - Analyst Target Price $3.99Ticker | QIPT |
Index | RUT |
Curent Price | 2.14 |
Change | 53.41% |
Market Cap | 92.96M |
Average Volume | 158.08K |
Income | -8.93M |
Sales | 240.85M |
Book Value/Share | 2.38 |
Cash/Share | 0.39 |
Dividend Est | - |
Dividend TTM | - |
Dividend Ex-Date | - |
Employees | 1200 |
Moving Avg 20days | 7.93% |
Moving Avg 50days | 0.81% |
Moving Avg 200days | -18.81% |
Shares Outstanding | 43.51M |
Earnings Date | May 12 AMC |
Inst. Ownership | 60.46% |
Price/Earnings | - |
Forwad P/E | - |
PE Growth | - |
Price/Sales | 0.39 |
Price/Book | 0.90 |
Price/Cash | 5.42 |
Price/FCF | 3.98 |
Quick Ratio | 0.85 |
Current Ratio | 1.22 |
Debt/Equity | 0.95 |
Return on Assets | -3.62% |
Return on Equity | -8.35% |
Return on Investment | -4.89% |
Gross Margin | 53.39% |
Ops Margin | 0.40% |
Profit Margin | -3.71% |
RSI | 55.56 |
BETA(β) | 0.32 |
From 52week Low | 58.52% |
From 52week High | -47.42% |
EPS | -0.21 |
EPS next Year | -0.20 |
EPS next Qtr | -0.04 |
EPS this Year | 38.61% |
EPS next 5 Year | -4.06% |
EPS past 5 Year | 13.26% |
Sales past 5 Year | 32.83% |
EPS Y/Y | -89.07% |
Sales Y/Y | -2.34% |
EPS Q/Q | -302.86% |
Sales Q/Q | -6.32% |
Sales Surprise | -7.20% |
EPS Surprise | -351.61% |
ATR(14) | 0.18 |
Perf Week | 28.14% |
Perf Month | 6.47% |
Perf Quarter | -19.55% |
Perf Year | -37.06% |
Perf YTD | -29.84% |
Target Price | 3.99 |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer